4.7 Review

Tight Junction Proteins and the Biology of Hepatobiliary Disease

期刊

出版社

MDPI
DOI: 10.3390/ijms21030825

关键词

Claudin; occludin; blood-biliary barrier; chronic liver disease; hepatocellular carcinoma; cholangiocellular carcinoma; NISCH syndrome

资金

  1. ARC, Paris
  2. Institut Hospital-Universitaire, Strasbourg (TheraHCC) [TheraHCC2.0IHUARCIHU201301187, IHUARC2019 IHU201901299]
  3. European Union [ERC-AdG-2014-671231-HEPCIR, EU H2020-667273-HEPCAR, ERC-PoC-2016-PRELICAN, ERC-PoC-2018HEPCAN]
  4. Agence nationale de recherche sur le sida et les hepatites virales (ANRS) [ECTZ35076]
  5. Foundation of the University of Strasbourg
  6. French National Research Agency as part of the Investments for the future
  7. German Research Foundation (DFG) [RO 5983/1-1]
  8. [LABEX ANR-10-LABX-0028_HEPSYS]

向作者/读者索取更多资源

Tight junctions (TJ) are intercellular adhesion complexes on epithelial cells and composed of integral membrane proteins as well as cytosolic adaptor proteins. Tight junction proteins have been recognized to play a key role in health and disease. In the liver, TJ proteins have several functions: they contribute as gatekeepers for paracellular diffusion between adherent hepatocytes or cholangiocytes to shape the blood-biliary barrier (BBIB) and maintain tissue homeostasis. At non-junctional localizations, TJ proteins are involved in key regulatory cell functions such as differentiation, proliferation, and migration by recruiting signaling proteins in response to extracellular stimuli. Moreover, TJ proteins are hepatocyte entry factors for the hepatitis C virus (HCV)-a major cause of liver disease and cancer worldwide. Perturbation of TJ protein expression has been reported in chronic HCV infection, cholestatic liver diseases as well as hepatobiliary carcinoma. Here we review the physiological function of TJ proteins in the liver and their implications in hepatobiliary diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据